This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Brian Vastag

JAMA. 2001;285:1435.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

New federal regulations are slated to make methadone treatment more flexible for physicians involved with approved addiction treatment programs, giving them the same latitude in treating opiate addiction that they have with other diseases. The regulations replace a 30-year-old US Food and Drug Administration (FDA) inspection program with an accreditation process administered by the Department of Health and Human Services' (DHHS) Center for Substance Abuse Treatment (CSAT).

While the old FDA system focused on controlling the amount of methadone dispensed—which usually forced patients to show up at a clinic every morning—the new regulations will allow physicians to develop individualized treatment plans. They will be able to prescribe several days' worth of methadone or another drug approved for opiate addiction, levo-alpha-acetyl-methadol (LAAM), if they think the patient is ready to handle it. The CSAT is funding studies to determine the feasibility of physicians prescribing these drugs from their own . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Torsade de Pointes Associated with Very-High-Dose Methadone
Krantz et al.
ANN INTERN MED 2002;137:501-504.
ABSTRACT | FULL TEXT